Cultivate your Potential.

Join ISCPDonate

Clinical Trials

Prognosis

CHAMPION-PHOENIX: A Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention

Deepak Bhatt et al

PARAMOUNT: Prospective Comparison of ARNI with ARB on Management of Heart Failure with Preserved Ejection Fraction

Scott Solomon et al.

RELAX TRIAL: Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

Jhon Teerlink, Gad Cotter,Beth Davison, et al

THE FREEDOM TRIAL: ” Future Revascularisation Evaluation in patients with diabetes mellitus: Optimal management of multivessel disease”

Valentin Fuster et al

: PARADIGM-HF. Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, et al

ODYSSEY Long Term Study

Robinson JG et al

Anti-inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Pablo Avanzas

6-Month Versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE): A Randomised, Open-label, Non-inferiority Trial

Albert Ferro

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

Pablo Avanzas

A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest

Pablo Avanzas

Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE Trial)

Pablo Avanzas

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis: the PIVOTAL trial

Sang Hong Baek

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

Krzysztof J. Filipiak

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia: The REDUCE-IT trial

Andréa Araujo Brandao

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

Ricardo Lopez Santi

Stay updated

ISCP Newsletter

Sign up to receive news and updates on our iniciatives, content and events.